Literature DB >> 18288095

Repeated stimulation of CRF receptors in the BNST of rats selectively induces social but not panic-like anxiety.

Younglim Lee1, Stephanie Fitz, Philip L Johnson, Anantha Shekhar.   

Abstract

Increased extra-hypothalamic corticotrophin-releasing factor (CRF) neurotransmission has been suggested as one putative factor in the pathophysiology of anxiety disorders. We have previously reported that administering repeated subanxiogenic doses (termed 'priming') of the CRF receptor agonist urocortin 1 (Ucn1) into the basolateral amygdala (BLA) of rats elicited long-lasting behavioral changes in social interaction (SI) and elevated plus maze (EPM) tests of anxiety. Although substantial similarity exists, the bed nucleus of the stria terminals (BNST) and the amygdala are thought to play distinct roles in anxiety responses. Rats primed with Ucn1 in the BLA not only demonstrated increased anxiety-like behaviors, but also physiological sensitivity to intravenous sodium lactate infusions, which is seen in subjects with panic or posttraumatic stress disorders, but not social or generalized anxiety disorders. In the present study, we tested if similar priming with subanxiogenic doses of Ucn1 in the BNST of rats will induce either chronic anxiety or sensitivity to sodium lactate. After determining the dose of Ucn1 that is subanxiogenic when injected into the BNST, repeated intra-BNST injections of this subanxiogenic dose of Ucn1 (6 fmol/100 nl) elicited persistent (present even after 4 weeks) anxiety-like responses in the SI but not EPM test. Prior local injection of a CRF receptor antagonist, astressin, into the BNST blocked this effect. Unlike Ucn1 priming in the BLA, rats primed in the BNST showed no cardiovascular changes following lactate infusion. Thus, BNST priming appears to selectively model the pathophysiology of subjects with anxiety syndromes like social anxiety, which are not lactate sensitive.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18288095      PMCID: PMC3065211          DOI: 10.1038/sj.npp.1301674

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  58 in total

Review 1.  Expression mechanisms underlying NMDA receptor-dependent long-term potentiation.

Authors:  R A Nicoll; R C Malenka
Journal:  Ann N Y Acad Sci       Date:  1999-04-30       Impact factor: 5.691

Review 2.  The intrinsic organization of the central extended amygdala.

Authors:  M D Cassell; L J Freedman; C Shi
Journal:  Ann N Y Acad Sci       Date:  1999-06-29       Impact factor: 5.691

3.  Excitatory amino acid receptor antagonists block the cardiovascular and anxiety responses elicited by gamma-aminobutyric acidA receptor blockade in the basolateral amygdala of rats.

Authors:  T J Sajdyk; A Shekhar
Journal:  J Pharmacol Exp Ther       Date:  1997-11       Impact factor: 4.030

4.  Role of corticotropin-releasing factor and urocortin within the basolateral amygdala of rats in anxiety and panic responses.

Authors:  T J Sajdyk; D A Schober; D R Gehlert; A Shekhar
Journal:  Behav Brain Res       Date:  1999-04       Impact factor: 3.332

5.  Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat: role of CRF receptor subtypes.

Authors:  Lacey L Sahuque; Erika F Kullberg; Andrew J Mcgeehan; Jennifer R Kinder; Megan P Hicks; Mary G Blanton; Patricia H Janak; M Foster Olive
Journal:  Psychopharmacology (Berl)       Date:  2006-03-28       Impact factor: 4.530

Review 6.  Pharmacotherapy of comorbid mood, anxiety, and substance use disorders.

Authors:  Kathleen T Brady; Marcia L Verduin
Journal:  Subst Use Misuse       Date:  2005       Impact factor: 2.164

7.  A role for corticotropin-releasing factor, but not corticosterone, in acute food-deprivation-induced reinstatement of heroin seeking in rats.

Authors:  Uri Shalev; Peter S Finnie; Tammie Quinn; Stephanie Tobin; Priti Wahi
Journal:  Psychopharmacology (Berl)       Date:  2006-06-01       Impact factor: 4.530

Review 8.  The extended amygdala: are the central nucleus of the amygdala and the bed nucleus of the stria terminalis differentially involved in fear versus anxiety?

Authors:  M Davis; C Shi
Journal:  Ann N Y Acad Sci       Date:  1999-06-29       Impact factor: 5.691

Review 9.  Role of noradrenergic projections to the bed nucleus of the stria terminalis in the regulation of the hypothalamic-pituitary-adrenal axis.

Authors:  María Inés Forray; Katia Gysling
Journal:  Brain Res Brain Res Rev       Date:  2004-12

10.  CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats.

Authors:  Y Shaham; S Erb; S Leung; Y Buczek; J Stewart
Journal:  Psychopharmacology (Berl)       Date:  1998-05       Impact factor: 4.530

View more
  41 in total

1.  Chronic anabolic androgenic steroid exposure alters corticotropin releasing factor expression and anxiety-like behaviors in the female mouse.

Authors:  Beth A Costine; Joseph G Oberlander; Matthew C Davis; Carlos A A Penatti; Donna M Porter; Robert N Leaton; Leslie P Henderson
Journal:  Psychoneuroendocrinology       Date:  2010-05-26       Impact factor: 4.905

Review 2.  Mad men, women and steroid cocktails: a review of the impact of sex and other factors on anabolic androgenic steroids effects on affective behaviors.

Authors:  Marie M Onakomaiya; Leslie P Henderson
Journal:  Psychopharmacology (Berl)       Date:  2016-01-12       Impact factor: 4.530

Review 3.  Don't stress about CRF: assessing the translational failures of CRF1antagonists.

Authors:  Samantha R Spierling; Eric P Zorrilla
Journal:  Psychopharmacology (Berl)       Date:  2017-03-07       Impact factor: 4.530

Review 4.  Orexin, stress, and anxiety/panic states.

Authors:  Philip L Johnson; Andrei Molosh; Stephanie D Fitz; William A Truitt; Anantha Shekhar
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

Review 5.  The Deakin/Graeff hypothesis: focus on serotonergic inhibition of panic.

Authors:  Evan D Paul; Philip L Johnson; Anantha Shekhar; Christopher A Lowry
Journal:  Neurosci Biobehav Rev       Date:  2014-03-21       Impact factor: 8.989

Review 6.  Sex differences in anxiety and emotional behavior.

Authors:  Nina C Donner; Christopher A Lowry
Journal:  Pflugers Arch       Date:  2013-04-16       Impact factor: 3.657

7.  Dopamine D2 receptor desensitization by dopamine or corticotropin releasing factor in ventral tegmental area neurons is associated with increased glutamate release.

Authors:  Sudarat Nimitvilai; Melissa Herman; Chang You; Devinder S Arora; Maureen A McElvain; Marisa Roberto; Mark S Brodie
Journal:  Neuropharmacology       Date:  2014-03-19       Impact factor: 5.250

Review 8.  Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety.

Authors:  Michael Davis; David L Walker; Leigh Miles; Christian Grillon
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

9.  Anxiogenic effects of CGRP within the BNST may be mediated by CRF acting at BNST CRFR1 receptors.

Authors:  K S Sink; A Chung; K J Ressler; M Davis; D L Walker
Journal:  Behav Brain Res       Date:  2013-02-01       Impact factor: 3.332

Review 10.  Optogenetic strategies to investigate neural circuitry engaged by stress.

Authors:  Dennis R Sparta; Joshua H Jennings; Randall L Ung; Garret D Stuber
Journal:  Behav Brain Res       Date:  2013-05-16       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.